The Amyloidosis Channel is supported through an educational grant from Alexion Pharma GmbH.

The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

EHA 2019 | ISA 2020: what to look forward to

Name: ISA 2020: what to look forward to
Uploaded: 2019-06-15T00:00:00.000Z
Duration: 1 min 39 s
Description: Joan Bladé, MD, Hospital Clinic, Barcelona, Spain, discusses the 17th International Symposium on Amyloidosis (ISA) in 2020, and what we can look forward to at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Joan Bladé • 15 Jun 2019

EHA 2019

Amyloidosis Multiple Myeloma Rare Diseases

Joan Bladé, MD, Hospital Clinic, Barcelona, Spain, discusses the 17th International Symposium on Amyloidosis (ISA) in 2020, and what we can look forward to at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.